NEW YORK (GenomeWeb) – Proteomics firm Biognosys said this week that it has licensed a patent from the Swiss Federal Institute of Technology Zurich covering a technology for capture of N-glycans.
The company said that it plans to use the technology to offer glycol-protein profiling as part of its high-resolution mass spec-based targeted quantitation offerings.
Developed by ETH Zurich research Ruedi Aebersold and colleagues at the Institute for Systems Biology in Seattle, the technique enables enrichment of N-glycosylated proteins.